glp 1 multiple endocrine neoplasia GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus Nutritional priorities to support GLP-1
Description
Key takeaways Ozempic (semaglutide), a diabetes medication, shows promise in improving PCOS symptoms by promoting weight loss and enhancing insulin sensitivity
This helps to better connect healthcare groups and patients
Careful monitoring of nutrition and lean mass should therefore be integrated into NDD trials
Incidences of acute pancreatitis and pancreatic cancer were reported to be increased with use of GLP-1RAs in the US Food and Drug Administrations database studies
